GLP-3 is an investigational multi‑receptor agonist targeting GLP‑1, GIP, and glucagon receptors. It is currently being researched for its potential effects on metabolic regulation and weight management.
For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.